These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 20950394)

  • 1. Clinical application of best practice guidelines for the genetic diagnosis of MODY2 and MODY3.
    Incani M; Cambuli VM; Cavalot F; Congiu T; Paderi M; Sentinelli F; Romeo S; Poy P; Soro M; Pilia S; Loche S; Cossu E; Trovati M; Mariotti S; Baroni MG
    Diabet Med; 2010 Nov; 27(11):1331-3. PubMed ID: 20950394
    [No Abstract]   [Full Text] [Related]  

  • 2. Mutations in GCK and HNF-1alpha explain the majority of cases with clinical diagnosis of MODY in Spain.
    Estalella I; Rica I; Perez de Nanclares G; Bilbao JR; Vazquez JA; San Pedro JI; Busturia MA; Castaño L;
    Clin Endocrinol (Oxf); 2007 Oct; 67(4):538-46. PubMed ID: 17573900
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low prevalence of MODY2 and MODY3 mutations in Brazilian individuals with clinical MODY phenotype.
    Furuzawa GK; Giuffrida FM; Oliveira CS; Chacra AR; Dib SA; Reis AF
    Diabetes Res Clin Pract; 2008 Sep; 81(3):e12-4. PubMed ID: 18672310
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic and clinical characteristics of maturity-onset diabetes of the young in Chinese patients.
    Xu JY; Dan QH; Chan V; Wat NM; Tam S; Tiu SC; Lee KF; Siu SC; Tsang MW; Fung LM; Chan KW; Lam KS
    Eur J Hum Genet; 2005 Apr; 13(4):422-7. PubMed ID: 15657605
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The type and the position of HNF1A mutation modulate age at diagnosis of diabetes in patients with maturity-onset diabetes of the young (MODY)-3.
    Bellanné-Chantelot C; Carette C; Riveline JP; Valéro R; Gautier JF; Larger E; Reznik Y; Ducluzeau PH; Sola A; Hartemann-Heurtier A; Lecomte P; Chaillous L; Laloi-Michelin M; Wilhem JM; Cuny P; Duron F; Guerci B; Jeandidier N; Mosnier-Pudar H; Assayag M; Dubois-Laforgue D; Velho G; Timsit J
    Diabetes; 2008 Feb; 57(2):503-8. PubMed ID: 18003757
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatocyte nuclear factor 1 alpha (HNF-1 alpha) mutations in maturity-onset diabetes of the young.
    Ellard S
    Hum Mutat; 2000 Nov; 16(5):377-85. PubMed ID: 11058894
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutations in the hepatocyte nuclear factor-4alpha gene in maturity-onset diabetes of the young (MODY1).
    Yamagata K; Furuta H; Oda N; Kaisaki PJ; Menzel S; Cox NJ; Fajans SS; Signorini S; Stoffel M; Bell GI
    Nature; 1996 Dec; 384(6608):458-60. PubMed ID: 8945471
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of novel GCK and HNF1A/TCF1 mutations and polymorphisms in German families with maturity-onset diabetes of the young (MODY).
    Toaima D; Näke A; Wendenburg J; Praedicow K; Rohayem J; Engel K; Galler A; Gahr M; Lee-Kirsch MA
    Hum Mutat; 2005 May; 25(5):503-4. PubMed ID: 15841481
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glucokinase mutations in young children with hyperglycemia.
    Codner E; Deng L; Pérez-Bravo F; Román R; Lanzano P; Cassorla F; Chung WK
    Diabetes Metab Res Rev; 2006; 22(5):348-55. PubMed ID: 16444761
    [TBL] [Abstract][Full Text] [Related]  

  • 10. GCK and HNF1A mutations in Canadian families with maturity onset diabetes of the young (MODY).
    Cao H; Shorey S; Robinson J; Metzger DL; Stewart L; Cummings E; Hegele RA
    Hum Mutat; 2002 Dec; 20(6):478-9. PubMed ID: 12442280
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutations in the hepatocyte nuclear factor-1alpha gene in maturity-onset diabetes of the young (MODY3).
    Yamagata K; Oda N; Kaisaki PJ; Menzel S; Furuta H; Vaxillaire M; Southam L; Cox RD; Lathrop GM; Boriraj VV; Chen X; Cox NJ; Oda Y; Yano H; Le Beau MM; Yamada S; Nishigori H; Takeda J; Fajans SS; Hattersley AT; Iwasaki N; Hansen T; Pedersen O; Polonsky KS; Bell GI
    Nature; 1996 Dec; 384(6608):455-8. PubMed ID: 8945470
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-penetrance in a MODY 3 family with a mutation in the hepatic nuclear factor 1alpha gene: implications for predictive testing.
    Miedzybrodzka Z; Hattersley AT; Ellard S; Pearson D; de Silva D; Harvey R; Haites N
    Eur J Hum Genet; 1999 Sep; 7(6):729-32. PubMed ID: 10482964
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic diabetic complications in patients with MODY3 diabetes.
    Isomaa B; Henricsson M; Lehto M; Forsblom C; Karanko S; Sarelin L; Häggblom M; Groop L
    Diabetologia; 1998 Apr; 41(4):467-73. PubMed ID: 9562352
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comment on: Clinical application of best practice guidelines for genetic diagnosis of MODY2.
    Salina A; Aloi C; Pasquali L; Mascagni A; Cassanello M; Tallone R; Lugani F; Lorini R; d'Annunzio G
    Diabetes Res Clin Pract; 2012 Feb; 95(2):e29-30. PubMed ID: 22119532
    [No Abstract]   [Full Text] [Related]  

  • 15. Pancreatic exocrine dysfunction in maturity-onset diabetes of the young type 3.
    Vesterhus M; Raeder H; Johansson S; Molven A; Njølstad PR
    Diabetes Care; 2008 Feb; 31(2):306-10. PubMed ID: 17989309
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Studies of hepatocyte nuclear factor (HNF)-1 alpha, HNF-4 alpha and HNF-1 beta genes in juvenile onset diabetes mellitus without obesity].
    Kagami M
    Hokkaido Igaku Zasshi; 2003 Jul; 78(4):339-47. PubMed ID: 12911009
    [No Abstract]   [Full Text] [Related]  

  • 17. Maturity-onset diabetes of the young (MODY), MODY genes and non-insulin-dependent diabetes mellitus.
    Velho G; Froguel P
    Diabetes Metab; 1997 Mar; 23 Suppl 2():34-7. PubMed ID: 9162575
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Non-insulin dependent diabetes in children and adolescents].
    Njølstad PR; Søvik O; Bell GI; Cockburn BN; Følling I; Sagen J
    Tidsskr Nor Laegeforen; 1998 Mar; 118(7):1054-7. PubMed ID: 9531829
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure/function studies of hepatocyte nuclear factor-1alpha, a diabetes-associated transcription factor.
    Yang Q; Yamagata K; Yamamoto K; Miyagawa J; Takeda J; Iwasaki N; Iwahashi H; Yoshiuchi I; Namba M; Miyazaki J; Hanafusa T; Matsuzawa Y
    Biochem Biophys Res Commun; 1999 Dec; 266(1):196-202. PubMed ID: 10581189
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Can molecular genetics help in the clinic?
    Hattersley A
    Diabet Med; 1999 Sep; 16(9):788-91. PubMed ID: 10510959
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.